Updated Jul 16, 2026
Rosa David A is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

David A. Rosa is the CEO and President of NeuroOne Medical Technologies Corp, a company specializing in technologies for brain-related conditions. He has held multiple roles within the company, including Director, and has been involved in its development of innovative medical technologies.
| Role | CEO and President, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-01 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 2.5K | $0.78 | $2K |
| 2026-02-20 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 71.3K | $0.68 | $49K |
| 2025-09-30 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 2.5K | $0.89 | $2K |
| 2025-06-30 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 2.5K | $0.68 | $2K |
| 2024-12-03 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 2.2K | $0.62 | $1K |
| 2024-11-01 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 2.2K | $0.97 | $2K |
| 2024-10-02 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 4.7K | $0.99 | $5K |
David A. Rosa is the CEO and President of NeuroOne Medical Technologies Corp, a company specializing in technologies for brain-related conditions. He has held multiple roles within the company, including Director, and has been involved in its development of innovative medical technologies.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Rosa David A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.